Allergic and Immunologic Diseases 2022
DOI: 10.1016/b978-0-323-95061-9.00032-1
|View full text |Cite
|
Sign up to set email alerts
|

The evaluation and treatment of autoimmune diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…Studies have also shown that GzmB is an important protein molecule involved in the pathogenesis of atopic dermatitis, and nonspecific GzmB activity also contributes to the formation of autoantigens in many autoimmune diseases (Darrah & Rosen, 2010). Currently, clinical evaluation of autoimmune diseases is largely based on invasive biopsy or conventional imaging modalities, including ultrasound and MRI, which often lack molecular specificity (Wiers-Shamir et al, 2022). In the treatment of autoimmune diseases, systemic administration of many immunosuppressants has produced mixed results, and the current lack of reliable monitoring tools limits the development and evaluation of new therapies.…”
Section: Systemic Autoimmune Diseasesmentioning
confidence: 99%
“…Studies have also shown that GzmB is an important protein molecule involved in the pathogenesis of atopic dermatitis, and nonspecific GzmB activity also contributes to the formation of autoantigens in many autoimmune diseases (Darrah & Rosen, 2010). Currently, clinical evaluation of autoimmune diseases is largely based on invasive biopsy or conventional imaging modalities, including ultrasound and MRI, which often lack molecular specificity (Wiers-Shamir et al, 2022). In the treatment of autoimmune diseases, systemic administration of many immunosuppressants has produced mixed results, and the current lack of reliable monitoring tools limits the development and evaluation of new therapies.…”
Section: Systemic Autoimmune Diseasesmentioning
confidence: 99%